EGFR and familial pancreatic carcinoma: Images were acquired at 0 h and 24 h of EGF treatment (1 ng/mL) alone and combined to treatment with erlotinib, an EGFR kinase activity inhibitor used in therapy of NSCLC and pancreatic cancer, to test the effect of Sorcin silencing in EGFR-dependent migration on H1299 cells.